Ramixotidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171960This classification denotes a histamine-2 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 957W618927. European Medicines Agency schedules Ramixotidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10250MIG. Ramixotidine generally arises in the molecular formula C16H21N3O3S. The term RAMIXOTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) RAMIXOTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ramixotidine under HS 29349990 and SITC 51579. As of Q4 2014, RAMIXOTIDINE remains the US FDA Preferred Term for this commodity. Ramixotidine bears US NLM identifiers UMLS ID C0139912 and NCI Concept Code C76679. SMILES: S(CC1OC(CN(C)C)CC1)CCNC(=O)C1C[N](O)CCC1.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.